Dapsone induced methaemoglobinaemia

International Journal of STD and AIDS

Volumn 7, Issue 6, 1996, Pages 445-447

  Landers, D ^a   Bergin, C ^a   O'Leary, A ^a   Merry, C ^a   Keating, S ^a   Mulcahy, F ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

Dapsone; HIV; ITP; Methaemoglobinaemia; PCP

Indexed keywords

DAPSONE;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; METHEMOGLOBINEMIA; PRIORITY JOURNAL;

ADULT; DAPSONE; FEMALE; HIV SEROPOSITIVITY; HUMANS; LEPROSTATIC AGENTS; MALE; METHEMOGLOBINEMIA;

EID: 0029798195     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462961918293     Document Type: Article

References (6)

1. Bozzette SA, Finkelstein DM, Spector SA (NIAID AIDS Clinical Trials Group). A randomised trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. N Engl J Med 1995;332: 693-9
2. Coker RJ, Tomlinson DR, Fisher M. Management of Pneumocystis carinii pneumonia. Int J STD AIDS 1995;6:167-73
3. Coleman MD. Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance. Br J Dermatol 1993;129:507-13
4. Coleman MD, Scott AK, Brekenbridge AM, Park BK. The use of cimetidine as a selective inhibitor of Dapsone-N-Hydroxylation in man. Br J Clin Pharmacol 1990;30:761-7
5. Kanto GS. Primaquine-induced methaemoglobinaemia during treatment of Pneumocystis carinii pneumonia. N Engl J Med 1992;327:1461
6. Durand JM, Lefevre P, Hovette P, Issifi S, Mongin M. Dapsone for thrombocytopenic purpura related to human immunodeficiency virus infection. Am J Med 1991;90:675-7